GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » PB Ratio

Square Pharmaceuticals (DHA:SQURPHARMA) PB Ratio : 1.48 (As of Apr. 29, 2025)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-29), Square Pharmaceuticals's share price is BDT215.40. Square Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was BDT145.52. Hence, Square Pharmaceuticals's PB Ratio of today is 1.48.

Good Sign:

Square Pharmaceuticals PLC stock PB Ratio (=1.48) is close to 10-year low of 1.39.

The historical rank and industry rank for Square Pharmaceuticals's PB Ratio or its related term are showing as below:

DHA:SQURPHARMA' s PB Ratio Range Over the Past 10 Years
Min: 1.39   Med: 2.22   Max: 4.83
Current: 1.48

During the past 13 years, Square Pharmaceuticals's highest PB Ratio was 4.83. The lowest was 1.39. And the median was 2.22.

DHA:SQURPHARMA's PB Ratio is ranked better than
60.13% of 928 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs DHA:SQURPHARMA: 1.48

During the past 12 months, Square Pharmaceuticals's average Book Value Per Share Growth Rate was 10.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 10.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Square Pharmaceuticals was 22.80% per year. The lowest was -44.20% per year. And the median was 17.00% per year.

Back to Basics: PB Ratio


Square Pharmaceuticals PB Ratio Historical Data

The historical data trend for Square Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals PB Ratio Chart

Square Pharmaceuticals Annual Data
Trend Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 2.06 1.83 1.61 1.48

Square Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 1.58 1.48 1.53 1.50

Competitive Comparison of Square Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Square Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Square Pharmaceuticals's PB Ratio falls into.


;
;

Square Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Square Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=215.40/145.521
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Square Pharmaceuticals  (DHA:SQURPHARMA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Square Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Square Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.

Square Pharmaceuticals Headlines

No Headlines